title: Silver nano particles prevent platelet adhesion on immobilized fibrinogen.
abstract: Vascular thrombotic disorders have emerged as a serious threat to our society. Platelet adhesion to fibrinogen, collagen and other platelet activators exposed over the atherosclerotic plaques can trigger platelet signaling events, activate platelets and lead to thrombotic events. Since anticoagulant and thrombolytic treatment strategies are usually associated with serious bleeding complications, preventing platelets adhesion may help to maintain platelets in an inactive state. In this study we tried to find out the effect of Silver nanoparticles, through their interaction with various platelet surface integrins on platelet adhesion on immobilized fibrinogen. Platelets, isolated from anti-coagulated human whole blood sample from healthy donors, were suspended in physiological buffer and each sample was divided into four tubes. In three of them 0.05, 0.5, and 5 μM concentrations of Silver nanoparticles were added, fourth tube served as control. Platelet adhesion on immobilized fibrinogen matrices and integrin mediated cell signaling events were studied in all the four samples. In the present study we show that nanosilver prevent platelet adhesion without conferring any lytic effect on them and effectively prevents integrin-mediated platelet responses in a concentration-dependent manner.
authors.affiliation: Department of Biochemistry, Subharti Medical College, Swami Vivekanand Subharti University, Subhartipuram, Delhi-Haridwar Bypass Road (N.H. 58), Meerut, 250005 Uttar Pradesh India.
authors.forename: Debapriya
authors.initials: D
authors.lastname: Bandyopadhyay
authors.forename: Haren
authors.initials: H
authors.lastname: Baruah
authors.forename: Bharat
authors.initials: B
authors.lastname: Gupta
authors.forename: Shailja
authors.initials: S
authors.lastname: Sharma
keywords: Adhesion; Cytoskeleton; Fibrinogen; Nanoparticles
references.citation: J Clin Invest. 2007 Apr;117(4):944-52
references.pmid: 17347685
references.citation: Physiol Rev. 1989 Jan;69(1):58-178
references.pmid: 2536184
references.citation: Nanomedicine (Lond). 2007 Oct;2(5):681-93
references.pmid: 17976030
references.citation: Nanotechnology. 2007 May 04;18(22):
references.pmid: 37016550
references.citation: Prog Cardiovasc Dis. 1999 Nov-Dec;42(3):217-33
references.pmid: 10598922
references.citation: Nano Lett. 2007 Jun;7(6):1542-50
references.pmid: 17465586
references.citation: Surg Neurol. 2004 Mar;61(3):216-20
references.pmid: 14984987
references.citation: Ann Pharmacother. 1995 Sep;29(9):892-905
references.pmid: 8547739
references.citation: Trends Cell Biol. 1998 Oct;8(10):390-6
references.pmid: 9789327
references.citation: J Biomed Mater Res A. 2006 Dec 1;79(3):665-74
references.pmid: 16832825
references.citation: Br J Pharmacol. 2005 Nov;146(6):882-93
references.pmid: 16158070
references.citation: Am Fam Physician. 2002 Mar 15;65(6):1097-102
references.pmid: 11925086
references.citation: Nanomedicine (Lond). 2006 Aug;1(2):201-8
references.pmid: 17716109
references.citation: Chest. 1999 Jun;115(6):1695-707
references.pmid: 10378570
references.citation: Nat Nanotechnol. 2008 Mar;3(3):145-50
references.pmid: 18654486
references.citation: BMJ. 2002 Dec 7;325(7376):1348-51
references.pmid: 12468488
references.citation: J Drug Target. 2001;9(4):267-79
references.pmid: 11697030
references.citation: Curr Pharm Biotechnol. 2005 Feb;6(1):17-33
references.pmid: 15727553
references.citation: ACS Nano. 2009 Feb 24;3(2):307-16
references.pmid: 19236065
references.citation: J Biol Chem. 2001 Mar 2;276(9):6703-10
references.pmid: 11084040
references.citation: Inhal Toxicol. 2007 Aug;19(10):857-71
references.pmid: 17687717